Results 11 to 20 of about 270,921 (246)

Comparative prognosis of pediatric lymphoblastic lymphoma: insights from Chinese and international cohorts [PDF]

open access: yesFrontiers in Oncology
ObjectiveThe aim of this research was to characterize the clinical features and histological subtypes of pediatric lymphoblastic lymphoma (LBL) and to assess the clinical prognostic factors for 178 pediatric patients.
Luyao Zhang   +9 more
doaj   +2 more sources

Cardiac tamponade as an initial atypical presentation of T-cell lymphoblastic lymphoma in a 17-year-old adolescent: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background T-cell lymphoblastic lymphoma is a type of non-Hodgkin’s lymphoma, which usually affects adolescents and young adults. The usual presentation is characterized by B symptoms and adenopathy associated with a mediastinal mass.
Mahamadou Charfo Bacharou   +4 more
doaj   +2 more sources

Transformation of Aggressive Non-Hodgkin Lymphoma in Acute Lymphoblastic Leukemia

open access: yesJournal of Interdisciplinary Medicine, 2017
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), representing up to 30 percent of all lymphomas. DLBCL is a fast-growing, aggressive form of NHL, which can appear as a transformation from a less aggressive form
Benedek István   +6 more
doaj   +3 more sources

Sellar B lymphoblastic lymphoma mimics pituitary apoplexy with newly discovered gene mutations in TP53 and PAX5: A case report

open access: yesFrontiers in Oncology, 2023
Lymphoblastic lymphoma (LBL) is a rare tumor that accounts for approximately 2-4% of all non-Hodgkin lymphomas, and less than 20% of LBLs are derived from B cells.
Yi Wang   +8 more
doaj   +1 more source

Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases

open access: yesCase Reports in Hematology, 2022
Treatment of early relapses of T lymphoblastic leukemia/lymphoma is often unsuccessful. We tested an experimental regimen containing daratumumab and nelarabine in two young patients with early relapses of T lymphoblastic lymphoma and T-ALL, respectively.
Ingolf Molle   +3 more
doaj   +1 more source

Expressió de ZAP-70 en linfòcits B normals i síndromes limfoproliferatives B [PDF]

open access: yes, 2006
[cat] La Leucèmia Limfàtica Crònica (LLC), la més freqüent de les leucèmies en el món occidental, és una malaltia produïda per la proliferació i cúmul de limfòcits B madurs, actualment incurable.
Crespo Maull, Marta
core   +6 more sources

Extranodal Biphenotypic Non-Hodgkin Lymphoma of the Popliteal Cavity: A Case Report and Review of Literature

open access: yesDiagnostics, 2022
Primary soft-tissue lymphoma (PSTL) is a rare extranodal non-Hodgkin lymphoma, characterized by a mass growing within soft-tissue, which is connective tissue, adipose tissue, and skeletal muscle.
Giulia A. Restivo   +8 more
doaj   +1 more source

Molecular mechanisms of follicular lymphoma and its transformation [PDF]

open access: yes, 2011
PhDFollicular lymphoma (FL) is the second most common form of non-Hodgkin lymphoma and at least a third of cases undergo aggressive transformation (t-FL), most frequently to diffuse large B-cell lymphoma.
Wrench, David John
core   +4 more sources

Analysis of non-Hodgkin's lymphoma by conventional cytogenetics and fluorescence in-situ hybridisation. [PDF]

open access: yes, 1995
Cytogenetic analysis was performed on 40 non-Hodgkin's lymphoma (NHQ node biopsies. Chromosomes X, 3 and 12 were the most frequently gained; of the much rarer monosomies, loss of chromosome 13 was most common.
Hammond, David William, Hammond, D.W.
core   +6 more sources

Lymphoblastic lymphoma in two young siblings (coincidence or genetics?): two case reports

open access: yesJournal of Medical Case Reports, 2021
Background Non-Hodgkin lymphoma is the fourth most common malignancy in children, and it is not considered to be a hereditary disorder. However, it could affect members from the same family.
Naya Talal Hassan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy